Man Group’s Cue Health Inc. Common Stock HLTH Stock Holding History

Man Group’s Portfolio HLTH Stock Details HLTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12,500	Closed	-$81K	–	2473
2022 Q1	$81K	Buy	+12,500	New	+$113K	﹤0.01%	2078

Other funds holding HLTH

Koch Industries Wichita, Kansas $853M AUM 37.49% 1-Year Est. Return

Oakmont Corp Los Angeles, California $526M AUM 7.52% 1-Year Est. Return

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JPC

Jabodon PT Co Reno, Nevada $1.02B AUM 22.14% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group's HLTH Position: Q2 2022 in Review

Man Group sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2022, closing a stake of 12,500 shares — an estimated $81K sold.

Man Group first reported a position in HLTH in Q1 2022 and held it in 1 quarter. The position peaked at $81K in Q1 2022. 99 funds tracked by Wall St. Rank hold HLTH as of Q2 2022.

Man Group reported no remaining Cue Health Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Man Group sold 12,500 Cue Health Inc. Common Stock shares in Q2 2022, an estimated $81K.
Man Group first reported a position in Cue Health Inc. Common Stock in Q1 2022 and held it in 1 quarter.
Man Group's Cue Health Inc. Common Stock position peaked at $81K in Q1 2022.
99 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2022.

Based on Man Group's 13F filing for Q2 2022, filed 15 Aug 2022.